MedTrace Logo

High Flow Nasal Cannula in Preterm Infants

NCT03007056 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 207

Last updated 2017-01-02

No results posted yet for this study

Summary

The HIFLO study evaluates the impact of HFNC oxygen therapy on duration of nCPAP therapy, oxygen therapy and hospitalization. The cost of use of CPAP and two HFNC devices are also evaluated.

Conditions

  • Prematurity; Extreme

Interventions

OTHER

High flow nasal cannula

High flow nasal cannula added to the therapeutic arsenal in neonatal care

Sponsors & Collaborators

  • Hôpital de la Croix-Rousse

    lead OTHER

Principal Investigators

  • jean-charles picaud, MD, PhD · Hopital de la croix rousse

Eligibility

Min Age
1 Day
Max Age
6 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2014-12-31
Completion
2016-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03007056 on ClinicalTrials.gov